Status:
COMPLETED
Probiotic on Atopic Dermatitis in Infant
Lead Sponsor:
Glac Biotech Co., Ltd
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
1-3 years
Phase:
NA
Brief Summary
The clinical trial will be carried out in China Medical University Hospital. The overall plan is a double-blind trial. All recruited 1-3 years old atopic dermatitis (AD) patients are divided into two ...
Eligibility Criteria
Inclusion
- Subjects were between 1 and 3 years old.
- For patients diagnosed with atopic dermatitis by a professional physician and the EASI score is greater than 10, the type and frequency of drugs used during the experiment should be recorded.
- The subject's parents agree to join the trial and sign the informed consent form.
Exclusion
- The patient who has a history of allergic reactions, or the use of other highly sensitive or contraindicated drugs (allergy to antibiotics or antipyretics).
- The patient who has taken oral immunosuppressants and systemic steroids within the past 2 weeks.
- The patient who has consumed probiotic-related products (including drops, lozenges, capsules, powder or yogurt) within the past 1 month.
- The patient who has participated in other clinical studies within the past 1 month.
- The patient who has received immunotherapy within the past 1 year.
- The patient who suffering from major diseases (with a IC card for severe illness), congenital diseases.
- The patient who is not suitable to participate in the trial as assessed by the professional physician.
Key Trial Info
Start Date :
September 23 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 28 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05286047
Start Date
September 23 2022
End Date
May 28 2025
Last Update
November 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Glac Biotech Co., Ltd.
Tainan, Taiwan, 74442